<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        133-124-22
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ANXETIN 20MG CAPSULES
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FLUOXETINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        529.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR Al DAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N06AB03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>Anxetin<sup>&reg;</sup></strong> contains the active substance fluoxetine which is one of a group of medicines called selective serotonin reuptake inhibitor (SSRI) antidepressants.</p><p dir="ltr">This medicine is used to treat the following conditions:</p><p dir="ltr"><strong>Adults</strong>:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Major depressive episodes</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Obsessive-compulsive disorder</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bulimia nervosa: <strong>Anxetin<sup>&reg;</sup></strong> is used alongside psychotherapy for the reduction of binge-eating and purging</p><p dir="ltr"><strong>Children and adolescents aged 8 years and above:</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Moderate to severe major depressive disorder, if the depression does not respond to psychological therapy after 4-6 sessions. <strong>Anxetin<sup>&reg;</sup></strong> should be offered to a child or young person with moderate to severe major depressive disorder only in combination with psychological therapy.</p><p dir="ltr">How <strong>Anxetin<sup>&reg;</sup></strong> works</p><p dir="ltr">Everyone has a substance called serotonin in their brain. People who are depressed or have obsessive-compulsive disorder or bulimia nervosa have lower levels of serotonin than others. It is not fully understood how <strong>Anxetin<sup>&reg;</sup></strong> and other SSRIs work but they may help by increasing the level of serotonin in the brain.</p><p dir="ltr">Treating these conditions is important to help you get better. If it&rsquo;s not treated, your condition may not go away and may become more serious and more difficult to treat.</p><p dir="ltr">You may need to be treated for a few weeks or months to ensure that you are free from symptoms.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>Do not take Anxetin<sup>&reg;</sup> if you are: </strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic to fluoxetine or any of the other ingredients of <strong>Anxetin<sup>&reg;</sup></strong>. If you develop a rash or other allergic reactions (like itching, swollen lips or face or shortness of breath), stop taking the capsules straight away and contact your doctor immediately.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking other medicines known as irreversible, non-selective monoamine oxidase inhibitors (MAOIs), since serious or even fatal reactions can occur (e.g. iproniazid used to treat depression). Treatment with <strong>Anxetin<sup>&reg;</sup></strong> should only be started at least 2 weeks after discontinuation of an irreversible, non-selective MAOI.</p><p dir="ltr">Do not<strong> </strong>take any irreversible, non-selective MAOIs for at least 5 weeks after you stop taking <strong>Anxetin<sup>&reg;</sup></strong>. If <strong>Anxetin<sup>&reg;</sup></strong> has been prescribed for a long period and/or at a high dose, a longer interval needs to be considered by your doctor.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking metoprolol (to treat heart failure) since there is an increased risk of your heart beat becoming too slow.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Take special care with Anxetin<sup>&reg;</sup> </strong></p><p dir="ltr">Tell your doctor or pharmacist before taking<strong> Anxetin<sup>&reg;</sup></strong> if any of the following applies to you:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; epilepsy or fits. If you have a fit (seizures) or experience an increase in seizure frequency, contact your doctor immediately; <strong>Anxetin<sup>&reg;</sup></strong> might need to be discontinued;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mania now or in the past; if you have a manic episode, contact your doctor immediately because <strong>Anxetin<sup>&reg;</sup></strong> might need to be discontinued;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diabetes (your doctor may need to adjust your dose of insulin or other anti-diabetic treatment);</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; liver problems (your doctor may need to adjust your dosage);</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart problems;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low resting heart-rate and/or if you know that you may have salt depletion as a result of prolonged severe diarrhoea and vomiting (being sick) or usage of diuretics (water tablets);</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; glaucoma (increased pressure in the eye);</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ongoing treatment with diuretics (water tablets), especially if you are elderly;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ongoing ECT (electro-convulsive therapy);</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; history of bleeding disorders or appearance of bruises or unusual bleeding;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ongoing treatment with medicines that thin the blood;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ongoing treatment with tamoxifen (used to treat breast cancer)<em>;</em></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; starting to feel restless and cannot sit or stand still (akathisia). Increasing your dose of <strong>Anxetin<sup>&reg;</sup></strong> may make this worse;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; appearance of fever, muscle stiffness or tremor, changes in your mental state like confusion, irritability and extreme agitation; you may suffer from the so-called &ldquo;serotonin syndrome&rdquo; or &ldquo;neuroleptic malignant syndrome&rdquo;. Although this syndrome occurs rarely it may result in potentially life threatening conditions; contact your doctor immediately, since <strong>Anxetin<sup>&reg;</sup></strong> might need to be discontinued.</p><p dir="ltr"><strong>Thoughts of suicide and worsening of your depression or anxiety disorder.</strong></p><p dir="ltr">If you are depressed and/or have anxiety disorders you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.</p><p dir="ltr">You may be more likely to think like this:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have previously had thoughts about killing or harming yourself.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are a young adult. Information from clinical trials has shown an increased risk of suicidal behaviour in adults aged less than 25 years with psychiatric conditions who were treated with an antidepressant.</p><p dir="ltr">If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.</p><p dir="ltr">You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.</p><p dir="ltr"><strong>&nbsp;&nbsp;children and adolescents aged 8 to 18 years:</strong></p><p dir="ltr">Patients under 18 have an increased risk of side-effects such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when they take this class of medicines. <strong>Anxetin<sup>&reg;</sup></strong> should only be used in children and adolescents aged 8 to 18 years for the treatment of moderate to severe major depressive episodes (in combination with psychological therapy) and it should not be used to treat other conditions.</p><p dir="ltr">Additionally, only limited information concerning the long-term safety of fluoxetine on growth, puberty, mental, emotional and behavioral development in this age group is available. Despite this, and if you are a patient under 18, your doctor may prescribe <strong>Anxetin<sup>&reg;</sup></strong> for moderate to severe major depressive episodes, in combination with psychological therapy, because he/she decides that this is in your best interests. If your doctor has prescribed <strong>Anxetin<sup>&reg;</sup></strong> for a patient under 18 and you want to discuss this, please go back to your doctor. You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 are taking <strong>Anxetin</strong><sup>&reg;</sup>. <strong>Anxetin<sup>&reg;</sup></strong> should not be used in the treatment of children under the age of 8 years.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Taking other medicines, herbal or dietary supplements</strong></p><p dir="ltr">tell your doctor or pharmacist if you are taking or have recently taken any other medicines. Do not take <strong>Anxetin<sup>&reg;</sup></strong><sup> </sup>with:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain irreversible, non-selective monoamine oxidase inhibitors (MAOIs), some used to treat depression. Irreversible, non-selective MAOIs must not be used with <strong>Anxetin<sup>&reg;</sup></strong> as serious or even fatal reactions (serotonin syndrome) can occur. Treatment with <strong>Anxetin<sup>&reg;</sup></strong> should only be started at least 2 weeks after discontinuation of an irreversible, non-selective MAOI (for instance tranylcypromine). Do not take any irreversible, non-selective MAOIs for at least 5 weeks after you stop taking <strong>Anxetin<sup>&reg;</sup></strong>. If <strong>Anxetin<sup>&reg;</sup></strong> has been prescribed for a long period and/or at a high dose, a longer interval than 5 weeks may need to be considered by your doctor.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; metoprolol when used for heart failure; there is an increased risk of your heart beat becoming too slow.</p><p dir="ltr"><strong>Anxetin<sup>&reg;</sup></strong> may affect the way the following medicines work (interaction):</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tamoxifen<strong> </strong>(used to treat breast cancer); because <strong>Anxetin<sup>&reg;</sup></strong> may change the blood levels of this drug, resulting in the possibility of a reduction in the effect of tamoxifen, your doctor may need to consider prescribing a different antidepressant treatment.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; monoamine oxidase inhibitors A (MAOI-A) including moclobemide, linezolid (an antibiotic) and methylthioninium chloride (also called methylene blue, used for the treatment of medicinal or chemical product induced methemoglobinemia): due to the risk of serious or even fatal reactions (called serotonin syndrome). Treatment with fluoxetine can be started the day after stopping treatment with reversible MAOIs but the doctor may wish to monitor you carefully and use a lower dose of the MAOI-A drug.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mequitazine<strong> </strong>(for allergies); because taking this drug with <strong>Anxetin</strong><sup>&reg;</sup> may increase the risk of changes in the electrical activity of the heart.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; phenytoin<strong> </strong>(for epilepsy); because <strong>Anxetin</strong><sup>&reg;</sup> may influence the blood levels of this drug, your doctor may need to introduce phenytoin more carefully and carry out check-ups when given with <strong>Anxetin</strong><sup>&reg;</sup>.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lithium, selegiline, St. John&rsquo;s Wort, tramadol (a painkiller), triptans (for migraine) and tryptophan; there is an increased risk of mild serotonin syndrome when these drugs are taken with <strong>Anxetin</strong><sup>&reg;</sup>. Your doctor will carry out more frequent check-ups.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that may affect the heart&rsquo;s rhythm, e.g. Class IA and III antiarrhythmics, antipsychotics (e.g. phenothiazine derivatives, pimozide, haloperidol), tricyclic antidepressants, certain antimicrobial agents (e.g. sparfloxacin, moxifloxacin, erythromycin IV, pentamidine), anti-malaria treatment particularly halofantrine or certain antihistamines (astemizole, mizolastine), because taking one or more of these drugs with <strong>Anxetin</strong><sup>&reg;</sup> may increase the risk of changes in the electrical activity of the heart.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anti-coagulants (such as warfarin), NSAID (such as ibruprofen, diclofenac), aspirin and other medicines which can thin the blood (including clozapine, used to treat certain mental disorders). <strong>Anxetin</strong><sup>&reg;</sup>may alter the effect of these medicines on the blood. If <strong>Anxetin</strong><sup>&reg;</sup> treatment is started or stopped when you are taking warfarin, your doctor will need to perform certain tests, adjust your dose and check on you more frequently.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cyproheptadine<strong> </strong>(for allergies); because it may reduce the effect of <strong>Anxetin</strong><sup>&reg;</sup>.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; drugs that lower sodium levels in the blood<strong> </strong>(including, drug that causes increase in urination, desmopressin, carbamazepine and oxcarbazepine); because these drugs may increase the risk of sodium levels in the blood becoming too low when taken with <strong>Anxetin</strong><sup>&reg;</sup>.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anti-depressants such as tricyclic anti-depressants, other selective serotonin reuptake inhibitors (SSRIs) or bupropion, mefloquine or chloroquine (used to treat malaria), tramadol (used to treat severe pain) or anti-psychotics<strong> </strong>such as phenothiazines or butyrophenones; because <strong>Anxetin</strong><sup>&reg;</sup> may increase the risk of seizures when taken with these medicines.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flecainide, propafenone, nebivolol or encainide (for heart problems), carbamazepine (for epilepsy), atomoxetine or tricyclic antidepressants (for example imipramine, desipramine and amitriptyline) or risperidone<strong> </strong>(for schizophrenia); because Prozac may possibly change the blood levels of these medicines, your doctor may need to lower their dose when administered with <strong>Anxetin</strong><sup>&reg;</sup>.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>Taking Anxetin<sup>&reg;</sup> with food and drink </strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You can take <strong>Anxetin<sup>&reg;</sup></strong> with or without food, whatever you prefer.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should avoid alcohol while you are taking this medicine.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Pregnancy, breast-feeding and fertility</strong></p><p dir="ltr"><strong>If you are pregnanat or breast feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. &nbsp;</strong></p><p dir="ltr"><em>Pregnancy</em></p><p dir="ltr">Talk to your doctor as soon as possible if you&#39;re pregnant, if you might be pregnant, or if you&#39;re planning to become pregnant.</p><p dir="ltr">In babies whose mothers took fluoxetine during the first few months of pregnancy, there have been some reports suggesting an increased risk of birth defects affecting the heart. In the general population, about 1 in 100 babies are born with a heart defect. This increased to about 2 in 100 babies in mothers who took fluoxetine.</p><p dir="ltr">When taken during pregnancy, particularly in the last 3 months of pregnancy, medicines like fluoxetine may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and appear bluish. These symptoms usually begin during the first 24 hours after the baby is born. If this happens to your baby you should contact your midwife and/or doctor immediately.</p><p dir="ltr">It is preferable not to use this treatment during pregnancy unless the potential benefit outweighs the potential risk. Thus, you and your doctor may decide to gradually stop taking <strong>Anxetin</strong><sup>&reg;</sup> while you are pregnant or before being pregnant. However, depending on your circumstances, your doctor may suggest that it is better for you to keep taking <strong>Anxetin</strong><sup>&reg;</sup>.</p><p dir="ltr">Caution should be exercised when used during pregnancy, especially during late pregnancy or just before giving birth since the following effects have been reported in new born children: irritability, tremor, muscle weakness, persistent crying, and difficulty in sucking or in sleeping.</p><p dir="ltr"><em>Breast-feeding</em></p><p dir="ltr">Fluoxetine is excreted in breast milk and can cause side effects in babies. You should only breast-feed if it is clearly necessary. If breast-feeding is continued, your doctor may prescribe a lower dose of fluoxetine.</p><p dir="ltr"><em>Fertility</em></p><p dir="ltr">Fluoxetine has been shown to reduce the quality of sperm in animal studies. Theoretically, this could affect fertility, but impact on human fertility has not been observed as yet.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Driving and using machines </strong></p><p dir="ltr">Psychotropic drugs such as<strong> Anxetin<sup>&reg;</sup></strong> may affect your judgment or co-ordination. Do not drive or use machinery until you know how <strong>Anxetin</strong><sup>&reg;</sup> affects you.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always take <strong>Anxetin<sup>&reg;</sup></strong> exactly as your doctor or pharmacist has told you. &nbsp;Check with your doctor or pharmacist if you are not sure. Do not take more capsules than your doctor tells you.</p><p dir="ltr">Swallow the capsules with a drink of water. Do not chew the capsules.</p><p dir="ltr"><strong>Adults:</strong></p><p dir="ltr">The recommended dose is:</p><p dir="ltr"><strong>Depression: </strong>The recommended dose is 1 capsule (20 mg) daily. Your doctor will review and adjust your dosage if necessary within 3 to 4 weeks of the start of treatment. If required, the dosage can be gradually increased up to a maximum of 3 capsules (60 mg) daily. The dose should be increased carefully to ensure that you receive the lowest effective dose. You may not feel better immediately when you first start taking your medicine for depression. This is usual because an improvement in depressive symptoms may not occur until after the first few weeks. Patients with depression should be treated for at least 6 months.</p><p dir="ltr"><strong>Bulimia nervosa: </strong>The recommended dose is 3 capsules (60 mg) daily.</p><p dir="ltr"><strong>Obsessive-compulsive disorder: </strong>The recommended dose is 1 capsule (20 mg) daily.</p><p dir="ltr">Your doctor will review and adjust your dosage if necessary after 2 weeks of treatment. If required, the dosage can be gradually increased up to a maximum of 3 capsules (60 mg) daily. If no improvement is noted within 10 weeks, your doctor will reconsider your treatment.</p><p dir="ltr"><strong>Use in Children and adolescents aged 8 to 18 years with depression:</strong></p><p dir="ltr">Treatment should be started and be supervised by a specialist. The starting dose of fluoxetine is 10mg/day. After 1 to 2 weeks, your doctor may increase the dose to 20mg/day. The dose should be increased carefully to ensure that you receive the lowest effective dose. Lower weight children may need lower doses. If there is a satisfactory response to treatment, your doctor will review the need for continuing treatment beyond 6 months. If you have not improved within 9 weeks, your doctor will reassess your treatment.</p><p dir="ltr"><strong>Elderly<em>:</em></strong></p><p dir="ltr">Your doctor will increase the dose with more caution and the daily dose should generally not exceed 2 capsules (40 mg). The maximum dose is 3 capsules (60 mg) daily.</p><p dir="ltr"><strong>Liver impairment:</strong></p><p dir="ltr">If you have a liver problem or are using other medication that might affect <strong>Anxetin<sup>&reg;</sup></strong>, your doctor may decide to prescribe a lower dose or tell you to use <strong>Anxetin<sup>&reg;</sup></strong> every other day.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>If you take more Anxetin<sup>&reg;</sup> than you should </strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you take too many capsules, go to your nearest hospital emergency department (or casualty) or tell your doctor straight away.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take the pack of <strong>Anxetin<sup>&reg;</sup></strong> with you if you can.</p><p dir="ltr">Symptoms of overdose include: Nausea, vomiting, seizures, heart problems (like irregular heart beat and cardiac arrest), lung problems and change in mental condition ranging from agitation to coma.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>If you forget to take Anxetin<sup>&reg;</sup> </strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you miss a dose, do not worry. Take your next dose the next day at the usual time. Do not take a double dose to make up for a forgotten dose.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking your medicine at the same time each day may help you to remember to take it regularly.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>If you stop taking Anxetin<sup>&reg;</sup> </strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not<strong> </strong>stop taking <strong>Anxetin<sup>&reg;</sup></strong> without asking your doctor first, even when you start to feel better. It is important that you keep taking your medicine.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make sure you do not run out of capsules.</p><p dir="ltr">You may notice the following effects (withdrawal effects) when you stop taking <strong>Anxetin<sup>&reg;</sup></strong>: dizziness; tingling feelings like pins and needles; sleep disturbances (vivid dreams, nightmares, inability to sleep); feeling restless or agitated; unusual tiredness or weakness; feeling anxious; nausea/vomiting (feeling sick or being sick); tremor (shakiness); headaches.</p><p dir="ltr">Most people find that any symptoms on stopping <strong>Anxetin<sup>&reg; </sup></strong>are mild and disappear within a few weeks. If you experience symptoms when you stop treatment, contact your doctor.</p><p dir="ltr">When stopping <strong>Anxetin<sup>&reg;</sup></strong>, your doctor will help you to reduce your dose slowly over one or two weeks - this should help reduce the chance of withdrawal effects.</p><p dir="ltr">If you have any further questions about the use of this medicine, ask your doctor or pharmacist.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, <strong>Anxetin<sup>&reg;</sup></strong> can cause side effects, although not everybody gets them.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you get a rash or allergic reaction such as itching, swollen lips/tongue or wheezing/shortness of breathe, stop taking the capsules straight away and tell your doctor immediately.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you feel restless and cannot sit or stand still, you may have akathisia; increasing your dose of <strong>Anxetin<sup>&reg;</sup></strong> may make you feel worse. If you feel like this, contact your doctor<strong>.</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tell your doctor immediately if your skin starts to turn red or you develop a varied skin reaction or your skin starts to blister or peel. This is very rare.</p><p dir="ltr">The most frequent sides effects (very common side effects that may affect more than 1 user in 10) are insomnia, headache, diarrhoea, feeling sick (nausea) and fatigue.</p><p dir="ltr">Some patients have had:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a combination of symptoms (known as &ldquo;serotonin syndrome&rdquo;) including unexplained fever with faster breathing or heart rate, sweating, muscle stiffness or tremor, confusion, extreme agitation or sleepiness (only rarely);</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feelings of weakness, drowsiness or confusion mostly in elderly people and in (elderly) people taking diuretics (water tablets);</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prolonged and painful erection;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irritability and extreme agitation;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart problems, such as fast or irregular heart rate, fainting, collapsing or dizziness upon standing which may indicate abnormal functioning of the heart rate.</p><p dir="ltr"><strong>If you have any of the above side effects, you should tell your doctor immediately.</strong></p><p dir="ltr">The following side effects have also been reported in patients taking <strong>Anxetin<sup>&reg;</sup></strong>:</p><p dir="ltr"><strong>Common </strong>(may affect up to 1 in 10 people)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; not feeling hungry, weight loss</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; nervousness, anxiety</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; restlessness, poor concentration</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; feeling tense</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; decreased sex drive or sexual problems (including difficulty maintaining an erection for sexual activity)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; sleep problems, unusual dreams, tiredness or sleepiness</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; change in taste</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; uncontrollable shaking movements</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; blurred vision</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; rapid and irregular heartbeat sensations</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; flushing</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; yawning</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; indigestion, vomiting</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; dry mouth</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; rash, urticaria, itching</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; excessive sweating</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; joint pain</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; passing urine more frequently</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; unexplained vaginal bleeding</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; feeling shaky or chills</p><p dir="ltr"><strong>Uncommon<em> </em></strong>(may affect up to 1 in 100 people)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; feeling detached from yourself</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; strange thinking</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; abnormally high mood</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; orgasm problems</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; teeth grinding</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; muscle twitching, involuntary movements or problems with balance or co-ordination</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; memory impairment</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; enlarged (dilated) pupils</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; ringing in the ears</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; low blood pressure</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; nose bleeds</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; difficulty swallowing</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; hair loss</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; increased tendency to bruising</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; unexplained bruising or bleeding</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; cold sweat</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; difficulty passing urine</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; feeling hot or cold</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; abnormal liver test results</p><p dir="ltr"><strong>Rare </strong>(may effect up to 1 in 1000 people)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; low levels of salt in the blood</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; reduction in blood platelets, which increases risk of bleeding or bruising.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; reduction in white blood cell count</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; untypical wild behaviour</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; hallucinations</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; agitation</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; panic attacks</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; confusion</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; stuttering</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; fits</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; vasculitis (inflammation of a blood vessel)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; rapid swelling of the tissues around the neck, face, mouth and/or throat</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; pain in the tube that takes food or water to your stomach</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; hepatitis</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; lung problems</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; sensitivity to sunlight</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; muscle pain</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; problems urinating</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp; producing breast milk</p><p dir="ltr"><strong>Bone fractures </strong>- an increased risk of bone fractures has been observed in patients taking this type of medicines.</p><p dir="ltr">Most of these side effects are likely to disappear with continued treatment.</p><p dir="ltr"><strong>In children and adolescents (8-18 years)</strong><em> </em>&ndash; In addition to the possible side effects listed above,<strong> Anxetin<sup>&reg;</sup></strong> may slow growth or possibly delay sexual maturity. Suicide related behaviors (suicide attempt and suicidal thoughts) hostility, mania and nose bleeds were also commonly reported in children.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Keep out of the reach and sight of children.</p><p dir="ltr">Do not use <strong>Anxetin</strong><sup>&reg;</sup> after the expiry date, which is stated on the carton after &ldquo;EXP&rdquo;: The expiry date refers to the last day of that month.</p><p dir="ltr">Protect from light. Store in a dry place. Do not store above 30&deg;C.</p><p dir="ltr">Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of any medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">The active substance<strong> </strong>is fluoxetine hydrochloride. Each capsule contains 20 mg fluoxetine (as fluoxetine. hydrochloride).</p><p dir="ltr">The other ingredients are: Magnesium stearate, microcrystalline cellulose, sodium starch glycolate, and mannitol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Anxetin® capsules 20 are capsules are opaque hard gelatin capsules with a yellow opaque body coded (Anxetin) and gray opaque cap coded (DAD). 
Anxetin® capsules are packed in blisters of 10. Anxetin® capsules are available in pack of 10 (1 blister), 20 (2 blisters) and 500 (50 blisters).
Not all pack sizes may be marketed. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Dar Al Dawa Development &amp; Investment Co Ltd (Na&rsquo;ur &ndash; Jordan).</p><p dir="ltr">Tel. (+962 6) 57 27 132</p><p dir="ltr">Fax. (+962 6) 57 27 776</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي <strong>انكسيتين</strong> على المادة الفعالة فلوكسيتين والتي تنتمي إلى مجموعة من الأدوية تسمى مضادات الإكتئاب من نوع &quot;المثبطات الانتقائية لإعادة استرجاع السيروتونين&quot; (SSRI).</p><p dir="RTL">يستخدم هذا الدواء في علاج الحالات التالية:</p><p dir="RTL"><strong>البالغين:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات الإكتئاب الجسيمة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إضطراب الوسواس القهري.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النهام العصبي: يستعمل<strong> انكسيتين</strong> إلى جانب العلاج النفسي للتقليل من إضطراب الإفراط في تناول الطعام والذي يتبعه التخلص المتعمد منه.</p><p dir="RTL"><strong>الأطفال والمراهقين من عمر 8 سنوات فأكثر:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لعلاج إضطراب الإكتئاب الجسيم المتوسط إلى الشديد, اذا لم تحدث إستجابة للعلاج النفسي بعد 4-6 جلسات. يمكن إعطاء <strong>انكسيتين</strong> للأطفال أو المراهقين الذين يعانون من الإكتئاب الشديد فقط بالتزامن مع العلاج النفسي.</p><p dir="RTL">الية عمل<strong> انكسيتين</strong></p><p dir="RTL">ان مادة السيريتونين موجودة في الدماغ عند كل الناس. يكون مستوى السيريتونين اقل لدى الاشخاص الذين يعانون من الاكتئاب او إضطراب الوسواس القهري او النهام العصبي. ان الية عمل <strong>انكسيتين</strong> ومثبطات اعادة امتصاص السيريتونين الاخرى غير مفهومة بشكل كامل الا انه من الممكن ان تقوم بدورها عن طريق زيادة مستوى السيريتونين في الدماغ.</p><p dir="RTL">انه من الهام علاج هذه الحالات للشعور بتحسن. في حال لم يتم علاجها قد لا تتلاشى وتصبح اكثر جدية. ويصبح علاجها اكثر صعوبة.</p><p dir="RTL">قد يستلزم العلاج عدة اسابع او شهور حتى تتلاشي الاعراض.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يمنع</strong><strong> </strong><strong>استعمال انكسيتين في حال:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من حساسية تجاه فلوكسيتين أو لأي من المكونات الأخرى في <strong>انكسيتين. </strong>إذا ظهر لديك طفح أو تفاعلات حساسية أخرى (مثل حكة، انتفاخ الشفاه أو الوجه أو ضيق التنفس)، توقف عن تناول هذه الكبسولات فورا واتصل بطبيبك في الحال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول أدوية أخرى تعرف بمثبطات أكسدة المركبات أحادية الامين غير العكوسة وغير الانتقائية (MAOIs)<strong>، </strong>بسبب إمكانية حدوث حالات خطيرة وأحيانا قاتلة (مثل ايبرونيازيد يستخدم لعلاج الاكتئاب). لا يمكن بدء العلاج ب <strong>انكسيتين</strong> الا بعد مرور اسبوعين على الأقل من التوقف عن استخدام مثبطات أكسدة المركبات أحادية الامين غير العكوسه وغير الانتقائية MAOI.</p><p dir="RTL">لا تتناول أي من مثبطات أكسدة المركبات أحادية الامين غير العكوسة وغير الانتقائية الا بعد مرور 5 اسابيع على الاقل من التوقف عن تناول انكسيتين<strong>.</strong> اذا تم وصف <strong>انكسيتين</strong> لفترة طويلة و/ أو بجرعات عالية ينبغي على طبيبك النظر في اطالة تلك الفترة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول ميتوبرولول (لعلاج سكتة قلبية) لوجود زيادة في خطر أن تصبح نبضات القلب بطيئة جدا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>استعمال انكسيتين </strong></p><p dir="RTL">تحدث إلى طبيبك او الصيدلي قبل تناول <strong>انكسيتين</strong> في حال وجود أي من الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصرع أو النوبات. اذا كنت تعاني من نوبات (إختلاجات) أو لاحظت ازدياد في تكرار الإختلاجات، اتصل بطبيبك على الفور؛ قد تحتاج الى التوقف عن تناول <strong>انكسيتين</strong>.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تعاني أو سبق وعانيت من الهوس؛ في حال حدثت نوبة هوس، اتصل بطبيبك على الفور لأنك قد تحتاج الى التوقف عن تناول <strong>انكسيتين</strong>.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السكري (قد يحتاج الطبيب الى تعديل جرعة الانسولين أو أي من العلاجات الاخرى المضادة للسكري)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الكبد (قد يحتاج الطبيب الى تعديل جرعتك)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض معدل ضربات القلب عند الراحة و / أو اذا كنت على علم بأنك قد تعاني من نقص في الاملاح نتيجة الاسهال الشديد المستمر والتقيؤ أو استخدام مدرات البول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الزرقة (إرتفاع ضغط العين)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تزامن العلاج مع مدرات البول، وخاصة عند كبار السن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تزامن العلاج بالتخليج الكهربائي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سبق حدوث اضطرابات في النزف أو ظهور كدمات أو نزيف غير اعتيادي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تزامن العلاج مع الادوية التي ترقق الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تزامن العلاج مع تاموكسيفين (يستخدم في علاج سرطان الثدي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بتململ مع عدم القدرة على الجلوس أو الوقوف بثبات (تعذر الجلوس). قد تصبح هذه الأعراض أسوأ في حال زيادة جرعة <strong>انكسيتين.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور حمى، تشنج العضلات أو إرتعاش، تغيرات في الحالة الذهنية مثل ارتباك، تهيج وإنفعال شديد؛ قد تعاني من حالة تسمى &quot;متلازمة سيروتونين&quot; أو &quot;متلازمة الذهان الخبيث&quot;. على الرغم من أن حدوث هذه المتلازمة نادر؛ الا انها قد تسبب حالات تهدد الحياة؛ اتصل بطبيبك فورا فقد تحتاج الى التوقف عن تناول انكسيتين<strong>.</strong></p><p dir="RTL"><strong>الأفكار الإنتحارية وتفاقم الإكتئاب وإضطراب القلق</strong></p><p dir="RTL">إذا كنت تعاني من الاكتئاب و/أو اضطرابات القلق قد تخطر لديك افكار بايذاء النفس أو الانتحار. قد تزيد هذه الاعراض عند بدء العلاج بمضادات الاكتئاب، لأن هذه الادوية تحتاج الى وقت لكي تعمل، حوالي اسبوعين عادة وفي بعض الاحيان قد تحتاج إلى وقت أطول.</p><p dir="RTL">قد تزيد احتمال ظهور افكار كهذه في حال:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني في السابق من أفكار تتعلق بالانتحار أو إيذاء النفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت من البالغين صغار السن. تم الإبلاغ عن حدوث زيادة في خطر السلوك الإنتحاري خلال التجارب السريرية في البالغين دون سن 25 عام الذين يعانون من اضطرابات نفسية عند علاجهم بمضادات الاكتئاب.</p><p dir="RTL">إذا كان لديك أفكار في أي وقت تتعلق بايذاء نفسك أو الانتحار، اتصل بالطبيب أو إذهب الى المستشفى فورا.</p><p dir="RTL">قد يكون من المفيد إخبار أحد أقربائك أو صديق مقرب<strong> </strong>لديك بأنك تعاني من الاكتئاب او اضطراب القلق، وأن تطلب منهم قراءة هذه النشرة، وإخبارك اذا كانوا يعتقدون بأن الاكتئاب أو القلق الذي تعاني منه أصبح اكثر سوءا، أو إذا كانوا قلقين من حدوث تغيرات في سلوكك.</p><p dir="RTL"><strong>الاستخدام في الاطفال والمراهقين الذين تتراوح أعمارهم بين 8 الى 18 سنة</strong>:</p><p dir="RTL">يزيد خطر ظهور أعراض جانبية مثل محاولات وافكار انتحارية وعدائية (غالبا سلوك عدواني, سلوك معارض وغضب) في المرضى دون 18 سنة ويتناولون أدوية من هذه الفئة. يستخدم <strong>انكسيتين</strong> في الاطفال والمراهقين (8-18 سنة) فقط لعلاج نوبات الإكتئاب الجسيمة المتوسطة إلى الشديدة (بالتزامن مع العلاج النفسي) ولا يستخدم في أي استطبابات اخرى.</p><p dir="RTL">بالاضافة الى ذلك، تعد البيانات المتوفرة عن مأمونية الاستخدام طويل الامد لفلوكسيتين في هذه المرحلة العمرية محدودة فيما يتعلق بتأثيره على النمو, البلوغ, التطورات العقلية، السلوكية والعاطفية. على الرغم من ذلك، اذا كنت مريضا دون 18 سنة، قد يصف لك الطبيب <strong>انكسيتين </strong>لعلاج نوبات نوبات الإكتئاب الجسيمة المتوسطة إلى الشديدة بالتزامن مع العلاج النفسي، لأنه/ لأنها قد يقرر بأن هذا في مصلحتك. اذا وصف الطبيب <strong>انكسيتين </strong>لمريض دون 18 سنة وتريد مناقشة ذلك، الرجاء زيارة الطبيب. يجب أن تخبره في حال ظهور أو تفاقم أي من الاعراض المذكورة أعلاه عندما يقل عمر المريض عن 18 عام.</p><p dir="RTL">لا ينبغي استخدام <strong>انكسيتين </strong>لعلاج الاطفال دون سن 8 سنوات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات</strong><strong> </strong><strong>الدوائية</strong><strong> </strong><strong>من</strong><strong> </strong><strong>أخذ</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>المستحضر</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>أعشاب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>مكملات غذائية</strong></p><p dir="RTL">الرجاء إخبار الطبيب او الصيدلي في حال كنت تأخذ أو قد قمت مؤخرا بأخذ اي أدوية اخرى.</p><p dir="RTL">لا تتناول <strong>انكسيتين</strong> مع التالي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أنواع محددة من مثبطات أكسدة المركبات أحادية الأمين غير العكوسة وغير الانتقائية، تستخدم بعضها في علاج الاكتئاب. لا ينبغي استخدام مثبطات أكسدة المركبات أحادية الأمين غير العكوسة وغير الانتقائية بالتزامن مع <strong>انكسيتين </strong>بسبب إمكانية حدوث تفاعلات شديدة وقد تكون مميتة &quot;متلازمة سيروتونين&quot;. يمنع بدء العلاج ب <strong>انكسيتين </strong>الا بعد مرور اسبوعين من وقف العلاج بمثبطات أكسدة المركبات أحادية الأمين غير العكوسة وغير الانتقائية (على سبيل المثال ترانيلسيبرومين). لا تتناول أي من مثبطات أكسدة المركبات أحادية الامين غير العكوسة وغير الانتقائية الا بعد مرور 5 اسابيع على الاقل من التوقف عن تناول <strong>انكسيتين.</strong> اذا تم وصف <strong>انكسيتين</strong> لفترة طويلة و/ أو بجرعات عالية ينبغي على طبيبك النظر في اطالة تلك الفترة أكثر من 5 أسابيع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول ميتوبرولول (لعلاج سكتة قلبية) لوجود زيادة في خطر أن تصبح نبضات القلب بطيئة جدا.</p><p dir="RTL"><strong>قد يؤثر انكسيتين</strong><strong> </strong><strong>على طريقة عمل بعض الادوية التالية (تداخل): </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تاموكسيفين<strong> </strong>(يستخدم في علاج سرطان الثدي)، لأن <strong>انكسيتين </strong>قد يغير من مستويات هذا الدواء في الدم والذي يؤدي الى احتمالية إنخفاض تأثير تاموكسيفين، قد يحتاج الطبيب الى وصف علاجات مختلفة من مضادات الاكتئاب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات أكسدة المركبات أحادية الامين نوع (MAOI-A) ويشمل موكلوبيمايد، لاينزولايد (مضاد حيوي) وميثيلثيونينيوم كلورايد (وأيضا يسمى ميثيلين بلو، يستخدم لعلاج ميثيموجلوبينيميا الناتجة عن مركب طبي أو كيميائية ): بسبب خطر حدوث تفاعلات شديدة أو قاتلة ( تسمى متلازمة سيروتونين). يمكن البدء بالعلاج مع فلوكسيتين في اليوم الذي يلي&nbsp; وقف العلاج بمثبطات أكسدة المركبات أحادية الامين العكوسة ولكن الطبيب قد يطلب مراقبتك عن كثب ويستخدم جرعة أقل من دواء مثبطات أكسدة المركبات أحادية الامين نوع A.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميكيوتازين (للحساسية)؛ لأن تناول هذا الدواء مع <strong>انكسيتين </strong>قد يزيد من خطر التغيرات في النشاط الكهربائي للقلب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فينيتوين (لعلاج الصرع): لأن <strong>انكسيتين</strong> قد يؤثر على مستويات فينيتوين في الدم. قد يحتاج الطبيب الى إعطاء فينيتوين بحذر اكثر عند استخدامه بالتزامن مع <strong>انكسيتين</strong> والقيام بفحوصات بشكل أكثر تكرارا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ليثيوم، سيليجيلين، عشبة سانت جونز، ترامادول (مسكن)، تريبتان (للشقيقة) وتريبتوفان؛ تحدث زيادة في خطر حدوث متلازمة السيروتونين عند اعطاء هذه الادوية بالتزامن مع <strong>انكسيتين</strong>. سيطلب منك طبيبك اجراء فحوصات بشكل أكثر تكرارا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الادوية التي قد تؤثر على معدل نظم القلب مثل الفئة الاولى أ و الفئة الثالثة من مضادات إضطراب النظم، مضادات الذهان<strong> </strong>(مثل مشتقات فينتيازين، بيموزيد، هالوبيريدول)، مضادات الاكتئاب ثلاثية الحلقة، أنواع معينة من مضادات<strong> </strong>الميكروبات (مثل سبارفلوكساسين، موكسيفلوكساسين، اريثرومايسين عن طريق الوريد، بينتاميدين)، مضادات الملاريا خصوصا هالوفانترين، أنواع معينة من مضادات الهيستامين (أستيميزول، ميزولاستين)، لأن تناول واحد أو أكثر من هذه الأدوية مع <strong>انكسيتين </strong>قد يزيد من خطر التغيرات في النشاط الكهربائي للقلب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات التخثر&nbsp; (مثل وارفارين)، مضادات الإلتهاب غير الستيرويدية (مثل ايبوبروفين، ديكلوفيناك)، أسبرين أو أي أدوية أخرى قد تعمل على تميع الدم (تشمل كلوزابين، يستخدم لعلاج انواع معينة من الاضطرابات العقلية). قد يغير <strong>انكسيتين</strong> من تأثير هذه الادوية على الدم. اذا بدأت أو توقفت عن تناول <strong>انكسيتين</strong> خلال الفترة التي تتلقى فيها الوارفارين، قد يحتاج الطبيب للقيام بفحوصات معينة، تعديل الجرعة او زيادة تكرار مراجعة الطبيب.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>سايبروهيبتادين (للحساسية)؛ لأنه قد يقلل من تأثير <strong>انكسيتين. </strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الأدوية التي تقلل من مستويات الصوديوم في الدم (تشمل، الدواء الذي يسبب زيادة في التبول، ديسموبريسين، كاربامازيبين واوكساكاربازيبين)؛ لأن هذه الأدوية تزيد من خطر أن تصبح مستويات الصوديوم في الدم قليلة عند تناولها مع انكسيتين.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>مضادات الاكتئاب مثل مضادات الاكتئاب ثلاثية الحلقة، مثبطات امتصاص السيروتونين الانتقائية (SSRIs) أو بيوبروبيون، ميفلوكوين أو كلوروكوين (يستخدم لعلاج الملاريا)، ترامادول (يستخدم لعلاج الالم الشديد) أو مضادات الذهان (مثل فينوثيازين أو بيوتيروفينونيز؛ لأن <strong>انكسيتين</strong> قد يزيد من خطر النوبات عند تناوله مع هذه الأدوية.&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فليكانيد، بروبافينون، نيبيفولول أو انكانيد (لمشاكل القلب)، كارباميزابين (للصرع)، اتوموكسيتين أو مضادات الاكتئاب ثلاثية الحلقة (مثل اميبرامين، ديسيبرامين و اميتريبتيلين) أو رسبيريدون (لانفصام الشخصية)؛ لأنه من الممكن أن يغير <strong>انكسيتين</strong> من مستويات هذه الادوية في الدم، قد يحتاج الطبيب الى تخفيض جرعات هذه الادوية عند إعطائها بالتزامن مع <strong>انكسيتين</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول انكسيتين مع الطعام والشراب </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من الممكن أن تتناول <strong>انكسيتين</strong> مع الطعام أو بدونه، أيهما تفضل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينبغي تجنب الكحول بالتزامن مع تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحم</strong><strong>ل</strong><strong>، الرضاعة </strong><strong>والخصوبة</strong></p><p dir="RTL">في حال كنت حامل ، مرضع، تشكين بانك حامل، أو تخططين لانجاب طفل استشيري طبيبك أو الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL"><em>الحمل</em></p><p dir="RTL">تحدثي الى طبيبك في أقرب وقت ممكن اذا كنت حامل، تتوقعين الحمل أو تخططين له.</p><p dir="RTL">تم الإبلاغ عن حدوث زيادة في خطر العيوب الخلقية التي تؤثر على القلب لدى الاطفال الذين تناولت امهاتهم فلوكسيتين خلال الاشهر الاولى من الحمل. بشكل عام، يولد طفل من بين كل 100 طفل لديه عيب في القلب. يزيد ذلك الى طفلين من بين كل 100 طفل في الأطفال الذين تناولت امهاتهم فلوكسيتين.</p><p dir="RTL">إن تناول ادوية مثل فلوكسيتين<strong> </strong>خلال الحمل، خصوصا في الاشهر الثلاث الاخيرة من الحمل، قد تؤدي الى زيادة خطر حدوث حالة خطيرة في الاطفال تعرف ب (فرط ضغط الدم الرئوي المستمر في حديثي الولادة)، والذي قد يجعل الطفل يتنفس بصورة أسرع مع لون مزرق. تبدأ هذه الاعراض بالظهور عادة خلال أول 24 ساعة بعد ولادة الطفل. اذا انطبقت هذه الاعراض على طفلك، يجب عليك الاتصال بالقابلة و /او الطبيب فورا.</p><p dir="RTL">من الأفضل عدم استخدام هذا العلاج خلال فترة الحمل الا اذا كانت الفائدة المرجوة تفوق&nbsp; احتمالية الخطر. لذلك انت وطبيبك قد تقرران وقف تناول <strong>انكسيتين</strong> تدريجياً خلال الحمل أو قبل الحمل. لكن على الرغم من ذلك ، بناء على ظروفك قد يقترح طبيبك أنه من الأفضل الاستمرار في تناول <strong>انكسيتين</strong>.</p><p dir="RTL">يجب توخي الحذر عند تناول هذا الدواء خلال الحمل، خصوصا في المراحل الاخيرة للحمل أو قبل الولادة مباشرة بسبب الإبلاغ عن التاثيرات التالية في الرضع حديثي الولادة: تهيج, رعاش, ضعف في العضلات , بكاء مستمر, صعوبة في الرضاعة أو النوم.</p><p dir="RTL"><em>الرضاعة</em></p><p dir="RTL">يتم طرح فلوكسيتين في حليب الام وقد يسبب آثار جانبية في الرضع. لا تقومي بالارضاع ما لم يكن ذلك ضروريا جدا. اذا استمريت في الارضاع، قد يصف لك الطبيب جرعة مخفضة من فلوكسيتين.</p><p dir="RTL"><em>الخصوبة </em></p><p dir="RTL">أظهرت الدراسات على الحيوانات أن فلوكسيتين قد يؤثر سلبا على نوعية الحيوانات المنوية. نظريا، قد يؤدي هذا الى العقم، لكن لم يلاحظ حدوث تأثير على الخصوبة في البشر بعد.</p><p dir="RTL">اطلب استشارة الطبيب أو الصيدلي قبل تناول أي دواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير انكسيتين على القيادة واستعمال الآلات:</strong></p><p dir="RTL">الأدوية النفسية مثل <strong>انكسيتين</strong> قد يؤثر على القرارات والتناسق. لا تقم بالقيادة او استخدام الآلات حتى تعرف كيف يؤثر <strong>انكسيتين </strong>عليك. &nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول <strong>انكسيتين</strong> حسب تعليمات الطبيب أو الصيدلي بدقة. يجب أن تتحقق من الطبيب او الصيدلي اذا لم تكن متأكدا. لا تتجاوز الجرعة التي حددها الطبيب.</p><p dir="RTL">إبلع الكبسولات مع كمية من الماء. لا تقم بمضغ الكبسولات.</p><p dir="RTL"><strong>البالغين</strong>:</p><p dir="RTL">الجرعة الموصى بها هي:</p><p dir="RTL"><strong>الاكتئاب</strong>: الجرعة الموصى بها هي كبسولة واحدة (20 ملغم) يوميا. قد يقوم الطبيب بتقييم وتعديل الجرعة خلال 3-4 اسابيع من بدء العلاج اذا تطلب الامر. من الممكن زيادة الجرعة تدريجيا إلى 3 كبسولات ( 60 ملغم) يومياً اذا اقتضت الحاجة. يجب زيادة الجرعة تدريجيا بحذر للتأكد من تناول المريض اقل جرعة فعالة. قد لا تشعر بتحسن بشكل فوري عند بدء تناول هذا الدواء لعلاج الاكتئاب. عادة لا يحدث تحسن في أعراض الاكتئاب الا بعد مرور الاسابيع القليلة الاولى. يجب أن يتم علاج مرضى الاكتئاب لمدة لا تقل عن ستة شهور.</p><p dir="RTL"><strong>النهام العصبي</strong><strong>:</strong> الجرعة الموصى بها هي 3 كبسولات ( 60 ملغم) يومياً.</p><p dir="RTL"><strong>الوسواس القهري:</strong> الجرعة الموصى بها هي كبسولة واحدة (20 ملغم) يوميا.</p><p dir="RTL">سيقوم الطبيب بتقييم وتعديل الجرعة خلال اسبوعين من بدء العلاج اذا تطلب الامر. من الممكن زيادة الجرعة تدريجيا إلى 3 كبسولات ( 60 ملغم) يومياً اذا اقتضت الحاجة. اذا يحدث تحسن خلال 10 أسابيع، فإن على الطبيب اعادة النظر في العلاج.</p><p dir="RTL"><strong>الاطفال والمراهقين من عمر 8 الى 18 سنة الذين يعانون من الاكتئاب: </strong></p><p dir="RTL">يجب ان يتم البدء بإستخدام الدواء ومتابعة المريض تحت اشراف طبيب مختص. الجرعة الابتدائية من فلوكسيتين هي 10 ملغم يومياً. يمكن زيادة الجرعة الى 20 ملغم يوميا بعد مرور اسبوع الى اسبوعين. يتم زيادة الجرعة بحذر حتى يتم التأكد من تناول اقل تركيز فعال. قد يحتاج الاطفال ذوي الوزن المنخفض الى جرعات اقل. سيقوم الطبيب بإعادة النظر في الحاجة لاستمرار العلاج لمدة تزيد عن 6 شهور لدى المرضى الذين اظهروا استجابة للعلاج, اذا لم يكن هناك تحسن خلال 9 اسابيع، يجب على الطبيب اعادة النظر في العلاج.</p><p dir="RTL"><strong>كبار السن: </strong></p><p dir="RTL">يجب على الطبيب توخي الحذر عند زيادة الجرعة على أن لا تتجاوز الجرعة اليومية عادة&nbsp; كبسولتين (40 ملغم). الجرعة القصوى الموصى بها هي 3 كبسولات (60 ملغم) يوميا.</p><p dir="RTL"><strong>إعتلال الكبد:</strong></p><p dir="RTL">قد يطلب الطبيب تقليل جرعة <strong>انكسيتين</strong> او يطلب تناوله يوم بعد يوم في المرضى الذين يعانون من اعتلال في وظائف الكبد أو الذين يستخدمون علاجا اخر قد يتداخل مع <strong>انكسيتين</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة</strong><strong> </strong><strong>الزائدة</strong><strong> </strong><strong>من</strong><strong> </strong><strong>انكسيتين</strong><strong> </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تناولت جرعة زائدة من الكبسولات، قم بزيارة أقرب مركز طوارئ أو أخبر طبيبك على الفور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قم بأخذ عبوة <strong>انكسيتين</strong><strong> </strong>معك<strong> </strong>إذا أمكن.</p><p dir="RTL">أعراض الجرعة الزائدة تشمل: غثيان، قيء، تشنجات, مشاكل في القلب (مثل عدم انتظام ضربات القلب وتوقف القلب), مشاكل في الرئة, وعلامات تغير في الحالة العقلية تتراوح من الاهتياج الى الغيبوبة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نسيان</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>جرعة</strong><strong> </strong><strong>انكسيتين</strong><strong> </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا نسيت تناول جرعة، لا تقلق. تناول الجرعة القادمة في اليوم التالي في وقتها المحدد. لا تضاعف الجرعة لتعويض الجرعة التي نسيتها.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن تناول الدواء في نفس الوقت من اليوم قد يساعدك على تذكر تناوله بانتظام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التوقف عن تناول انكسيتين</strong><strong> </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتوقف عن تناول <strong>انكسيتين</strong> دون إخبار الطبيب أولا، حتى وإن بدأت تشعر بتحسن. من المهم أن تستمر في تناول هذا الدواء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تأكد من عدم نفاد الكبسولات منك.</p><p dir="RTL">قد تظهر الاعراض التالية (أعراض الانسحاب) عند توقف عن تناول <strong>انكسيتين</strong>: دوخة, شعور بالوخز والتنميل، اضطرابات في النوم (احلام اليقظة، كوابيس، ارق), الشعور بتململ أو تهيج, تعب غير اعتيادي أو ضعف، الشعور بالقلق، غثيان / قيء, رعاش, صداع.</p><p dir="RTL">يجد معظم الناس أن أي أعراض قد تحدث بعد التوقف عن تناول <strong>انكسيتين</strong><strong> </strong>تكون طفيفة وتختفي في غضون عدة اسابيع. اذا حدثت لك أعراض بعد توقف العلاج، اتصل بطبيبك.</p><p dir="RTL">عند التوقف عن استخدام <strong>انكسيتين</strong>، سيساعدك الطبيب في خفض الجرعة تدريجيا خلال فترة اسبوع أو اسبوعين &ndash; سيساعدك هذا في تقليل فرصة حدوث اعراض الانسحاب.</p><p dir="RTL">إذا كان لديك إستفسارات أخرى حول استخدام هذا الدواء إستشر طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن الادوية الأخرى قد يسبب <strong>انكسيتين</strong> اعراضا جانبية, الا انها لا تحدث عند كل المرضى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كانت لديك أفكار في أي وقت تتعلق بإيذاء نفسك أو الانتحار، اتصل بالطبيب أو اذهب الى المستشفى على الفور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا ظهر لديك طفح أو تفاعلات حساسية مثل حكة، انتفاخ الشفاه/اللسان أو صفير/ضيق التنفس، توقف عن تناول الكبسولات فورا وأخبر طبيبك على الفور.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>اذا كنت تشعر بتململ مع عدم القدرة على الجلوس أو الوقوف بثبات، قد تعاني من تعذر الجلوس. قد تصبح هذه الاعراض أسوأ عند زيادة جرعة <strong>انكسيتين.</strong> اذا شعرت بهذه الاعراض، اتصل بطبيبك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخبر طبيبك على الفور اذا بدأ جلدك بالاحمرار أو حدثت لك تفاعلات جلدية مختلفة أو بدأ جلدك بالتقشر أو التقرح. يعد حدوث ذلك نادر جدا.</p><p dir="RTL">الأعراض الجانبية الأكثر تكرار (أعراض جانبية شائعة جداً قد تؤثر على أكثر من 1 من بين 10 أشخاص) هي أرق، صداع، اسهال، غثيان، وتعب.</p><p dir="RTL">قد يحدث لدى المرضى:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مجموعة من الاعراض ( تعرف ب &quot; متلازمة سيروتونين&quot;) و تشمل حمى غير مبررة مع زيادة في سرعة التنفس أو معدل ضربات القلب، تعرق، تصلب عضلي أو ارتعاش، ارتباك، اهتياج شديد أو نعاس ( تحدث فقط بشكل نادر).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالضعف، نعاس او إرتباك غالبا لدى كبار السن و كبار السن الذين يتناولون مدرات البول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتصاب لوقت طويل مع ألم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تهيج و انفعال مفرط</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في القلب مثل سرعة أو عدم انتظام في ضربات القلب، إغماء، اختناق او دوخة عند الوقوف، تشير هذه الاعراض الى أداء غير طبيعي في معدل ضربات القلب.</p><p dir="RTL"><strong>اذا حدثت لك اي من الاعراض الجانبية السابقة، يجب عليك إخبار الطبيب على الفور.</strong></p><p dir="RTL">تم الإبلاغ عن الاعراض الجانبية التالية في المرضى الذين يتناولون <strong>انكسيتين</strong>:</p><p dir="RTL">شائع ( بتكرار لايتجاوز شخص من&nbsp; 10)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم الشعور بالجوع، فقدان الوزن</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عصبية، قلق</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب، ضعف التركيز</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتوتر</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض الرغبة الجنسية أو حدوث مشاكل جنسية ( تشمل صعوبة في الابقاء على الانتصاب للنشاط الجنسي)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في النوم، احلام غير اعتيادية، تعب أو نعاس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوخة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغير في التذوق</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حركات اهتزازية لا يمكن السيطرة عليها</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم وضوح الرؤية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاحساس بضربات قلب سريعة وغير منتظمة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تثاؤب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عسر الهضم، قيء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح، شرى، حكة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعرق شديد</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الم في المفاصل</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في تكرار التبول</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف مهبلي غير مبرر</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالارتعاش أو القشعريرة</p><p dir="RTL">غير شائع (بتكرار لايتجاوز شخص من كل 100)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالانفصال عن نفسك</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التفكير بشكل غريب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مزاج عالي غير طبيعي</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في النشوة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صرير الاسنان</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف الذاكرة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتعاش العضلات، حركات لا ارادية او مشاكل في التوازن اوالتناسق</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; توسع بؤبؤ العين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طنين في الأذن</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رعاف</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في البلع</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشعر</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الميل الى ظهور الكدمات</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور كدمات او ادماء بدون سبب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عرق بارد</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في ادرار البول</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالحر او البرد</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نتائج غير طبيعية لفحوصات الكبد</p><p dir="RTL">نادر ( شوهد في 1-10 من كل 10000 مريض)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض مستوى الأملاح في الدم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في الصفائح الدموية، مما يزيد من خصر الادماء والكدمات.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سلوك جامح غير عادي</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدم البيضاء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هلوسة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اهتياج</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات ذعر</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتباك</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تلعثم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختلاجات</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الاوعية الدموية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ سريع في الانسجة حول الرقبة، الوجه، الفم و/ أو الحلق</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الم في القناة التي تنقل الطعام او الماء الى معدتك (المريء)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل الرئتين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية تجاه أشعة الشمس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجع العضلات</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل التبول</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتاج حليب في الثدي</p><p dir="RTL"><strong>كسور في العظام</strong> &ndash; تم الإبلاغ عن زيادة في خطورة حدوث كسور في العظم في المرضى الذين يتناولون هذا النوع من الادوية.</p><p dir="RTL">اذا حدث لك أي من الاعراض المذكورة أعلاه وكانت تزعجك، أو استمرت لفترة طويلة، أخبر طبيبك أو الصيدلي.</p><p dir="RTL">معظم هذه الاعراض غالبا ستختفي مع استمرار العلاج.</p><p dir="RTL"><strong>في الاطفال والمراهقين (8- 18 سنة) </strong><strong>-</strong> بالاضافة الى الاعراض الجانبية المحتملة المذكورة أعلاه، قد يسبب <strong>انكسيتين</strong> بطء في النمو و تأخر في النضوج الجنسي. تم رصد تصرفات مرتبطة بالانتحار(محاولات انتحار وافكار انتحارية) عنف ، هوس ورعاف بشكل شائع لدى الاطفال.</p><p dir="RTL">اذا أصبحت أي من الاعراض الجانبية خطيرة او اذا لاحظت حدوث اي اعراض جانبية غير المذكورة في هذه النشرة، الرجاء إخبار الطبيب او الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ <strong>انكسيتين</strong> بعيدا عن متناول أيدي الأطفال ونظرهم.</p><p dir="RTL">لا تستخدم <strong>انكسيتين</strong> بعد تاريخ الإنتهاء المذكور على العبوة. يدل تاريخ الإنتهاء على اخر يوم من الشهر المذكور.</p><p dir="RTL">يحفظ بعيدا عن الضوء. يحفظ في مكان جاف على درجة حرارة لا تزيد عن 30 درجة مئوية.</p><p dir="RTL">لا تتخلص من الأدوية في المياه العادمة أو النفايات المنزلية. اسأل الصيدلي حول الطريقة السليمة للتخلص من الادوية التي لم تعد بحاجة اليها. سيساعد هذا في حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي فلوكسيتين هيدروكلورايد. تحتوي كل كبسولة على 20 ملغم فلوكسيتين (على هيئة فلوكسيتين هيدروكلورايد).</p><p dir="RTL">المواد غير الفعالة الأخرى: ستيارات المغنيسيوم، سيليلوز دقيق البلورية، أملاح الصوديوم لجلايكولات النشا ومانيتول.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كبسولات<strong> انكسيتين </strong>20 هي كبسولات جيلاتينية صلبة غير شفافة ذات جسم اصفر مرمزة بالرمز (Anxetin) وغطاء رمادي مرمز بالرمز (DAD)<strong>.</strong></p><p dir="RTL">كبسولات <strong>انكسيتين</strong> مغلفة داخل اشرطة يحتوي كل منها 10 كبسولات. <strong>انكسيتين</strong> متوفر في عبوات 10 كبسولات (شريط واحد)، 20 (شريطين) و500 ( 50 شريط).</p><p dir="RTL">قد لا يتم تسويق جميع العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة دار الدواء للتنمية والإستثمار المساهمة المحدودة (ناعور- الأردن)</p><p dir="RTL">هاتف. 132 27 57 (6 962 +)</p><p dir="RTL">فاكس.776 27 57 (6 962 +)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            05/2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Anxetin® 20 Capsules 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Anxetin® 20 capsules. Each capsule contains 20 mg Fluoxetine (as fluoxetine hydrochloride).
For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capsules 
Anxetin® 20 mg capsules are capsules with yellow opaque body coded (Anxetin 20) and gray opaque cap coded (DAD).

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Adults:</em></p><p dir="ltr"><em>Major depressive episodes</em>.</p><p dir="ltr"><em>Obsessive-compulsive disorder</em>.</p><p dir="ltr"><em>Bulimia nervosa:</em> Anxetin<sup>&reg;</sup> is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.</p><p dir="ltr"><em>Children and Adolescents Aged 8 Years and Above:</em></p><p dir="ltr">Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. Antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Posolgy</u></p><p dir="ltr"><u>Adults</u></p><p dir="ltr">For oral administration.</p><p dir="ltr"><em>Major depressive episodes</em></p><p dir="ltr">Adults and the elderly: The recommended dose is 20mg daily. Dosage should be reviewed and adjusted if necessary, within 3 to 4 weeks of initiation of therapy and thereafter as judged clinically appropriate. Although there may be an increased potential for undesirable effects at higher doses, in some patients, with insufficient response to 20mg, the dose may be increased gradually up to a maximum of 60mg (see section 5.1). Dosage adjustments should be made carefully on an individual patient basis, to maintain the patients at the lowest effective dose.</p><p dir="ltr">Patients with depression should be treated for a sufficient period of at least 6 months to ensure that they are free from symptoms.</p><p dir="ltr"><em>Obsessive-compulsive disorder</em></p><p dir="ltr">Adults and the elderly: The recommended dose is 20mg daily. Although there may be an increased potential for undesirable effects at higher doses, in some patients, if after two weeks there is insufficient response to 20mg, the dose may be increased gradually up to a maximum of 60mg.</p><p dir="ltr">If no improvement is observed within 10 weeks, treatment with fluoxetine should be reconsidered. If a good therapeutic response has been obtained, treatment can be continued at a dosage adjusted on an individual basis. While there are no systematic studies to answer the question of how long to continue fluoxetine treatment, OCD is a chronic condition and it is reasonable to consider continuation beyond 10 weeks in responding patients. Dosage adjustments should be made carefully on an individual patient basis, to maintain the patient at the lowest effective dose. The need for treatment should be reassessed periodically. Some clinicians advocate concomitant behavioural psychotherapy for patients who have done well on pharmacotherapy.</p><p dir="ltr">Long-term efficacy (more than 24 weeks) has not been demonstrated in OCD.</p><p dir="ltr"><em>Bulimia nervosa:</em> Adults and the elderly: A dose of 60mg/day is recommended. Long-term efficacy (more than 3 months) has not been demonstrated in bulimia nervosa.</p><p dir="ltr"><em>All indications:</em> Adults: The recommended dose may be increased or decreased. Doses above 80mg/day have not been systematically evaluated.</p><p dir="ltr"><u>Paediatric population - Children and adolescents aged 8 years and above (moderate to severe major depressive episode)</u></p><p dir="ltr">Treatment should be initiated and monitored under specialist supervision. The starting dose is 10mg/day. Dose adjustments should be made carefully, on an individual basis, to maintain the patient at the lowest effective dose.</p><p dir="ltr">After one to two weeks, the dose may be increased to 20mg/day. Clinical trial experience with daily doses greater than 20mg is minimal. There is only limited data on treatment beyond 9 weeks.</p><p dir="ltr"><em>Lower-weight children:</em> Due to higher plasma levels in lower-weight children, the therapeutic effect may be achieved with lower doses (see section 5.2).</p><p dir="ltr">For paediatric patients who respond to treatment, the need for continued treatment after 6 months should be reviewed. If no clinical benefit is achieved within 9 weeks, treatment should be reconsidered.</p><p dir="ltr"><u>Elderly patients</u></p><p dir="ltr">Caution is recommended when increasing the dose, and the daily dose should generally not exceed 40mg. Maximum recommended dose is 60mg/day.</p><p dir="ltr"><u>Hepatic impairment</u></p><p dir="ltr">A lower or less frequent dose (e.g., 20mg every second day) should be considered in patients with hepatic impairment (see section 5.2), or in patients where concomitant medication has the potential for interaction with fluoxetine (see section 4.5).</p><p dir="ltr"><em>Withdrawal symptoms seen on discontinuation of </em><em>Anxetin</em><sup>&reg;</sup><em>:</em> Abrupt discontinuation should be avoided. When stopping treatment with Anxetin<sup>&reg;</sup> the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see section 4.4 and section 4.8). If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered. Subsequently, the physician may continue decreasing the dose, but at a more gradual rate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Fluoxetine is contra-indicated in combination with irreversible, non-selective monoamine oxidase inhibitors (e.g. iproniazid) (see sections 4.4 and 4.5).
Fluoxetine is contra-indicated in combination with metoprolol used in cardiac failure (see section 4.5).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Paediatric population - Children and adolescents under 18 years of age:</em><em> </em>Suicide-related behaviours (suicide attempt and suicidal thoughts) and hostility (predominantly aggression, oppositional behaviour and anger) were more frequently observed in clinical trials among children and adolescents treated with antidepressants compared to those treated with placebo. Fluoxetine should only be used in children and adolescents aged 8 to 18 years for the treatment of moderate to severe major depressive episodes and it should not be used in other indications. If, based on clinical need, a decision to treat is nevertheless taken, the patient should be carefully monitored for the appearance of suicidal symptoms. In addition, only limited evidence is available concerning long-term effect on safety in children and adolescents, including effects on growth, sexual maturation and cognitive, emotional and behavioural developments (see section 5.3).</p><p dir="ltr">In a 19-week clinical trial, decreased height and weight gain was observed in children and adolescents treated with fluoxetine (see section 5.1). It has not been established whether there is an effect on achieving normal adult height. The possibility of a delay in puberty cannot be ruled out (see sections 5.3 and 4.8). Growth and pubertal development (height, weight, and TANNER staging) should therefore be monitored during and after treatment with fluoxetine. If either is slowed, referral to a paediatrician should be considered.</p><p dir="ltr">In paediatric trials, mania and hypomania were commonly reported (see section 4.8). Therefore, regular monitoring for the occurrence of mania/hypomania is recommended. Fluoxetine should be discontinued in any patient entering a manic phase.</p><p dir="ltr">It is important that the prescriber discusses carefully the risks and benefits of treatment with the child/young person and/or their parents.</p><p dir="ltr"><em>Suicide/suicidal thoughts or clinical worsening: </em>Depression is associated with an increased risk of suicidal thoughts, self-harm and suicide (suicide-related events). This risk persists until significant remission occurs. As improvement may not occur during the first few weeks or more of treatment, patients should be closely monitored until such improvement occurs. It is general clinical experience that the risk of suicide may increase in the early stages of recovery.</p><p dir="ltr">Other psychiatric conditions for which Anxetin<sup>&reg;</sup> is prescribed can also be associated with an increased risk of suicide-related events. In addition, these conditions may be co-morbid with major depressive disorder. The same precautions observed when treating patients with major depressive disorder should therefore be observed when treating patients with other psychiatric disorders.</p><p dir="ltr">Patients with a history of suicide-related events, those exhibiting a significant degree of suicidal ideation prior to commencement of treatment are known to be at greater risk of suicidal thoughts or suicide attempts, and should receive careful monitoring during treatment. A meta-analysis of placebo-controlled clinical trials of antidepressants drugs in adult patients with psychiatric disorders showed an increased risk of suicidal behaviour with antidepressants compared to placebo in patients less than 25 years old.</p><p dir="ltr">Close supervision of patients and in particular those at high risk should accompany drug therapy especially in early treatment and following dose changes. Patients (and caregivers of patients) should be alerted about the need to monitor for any clinical worsening, suicidal behaviour or thoughts and unusual changes in behaviour and to seek medical advice immediately if these symptoms present.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Cardiovascular Effects</em>: Cases of QT interval prolongation and ventricular arrhythmia including torsade de pointes have been reported during the post-marketing period (see sections 4.5, 4.8 and 4.9).</p><p dir="ltr">Fluoxetine should be used with caution in patients with conditions such as congenital long QT syndrome, a family history of QT prolongation or other clinical conditions that predispose to arrhythmias (e.g., hypokalemia and hypomagnesemia, bradycardia, acute myocardial infarction or uncompensated heart failure) or increased exposure to fluoxetine (e.g., hepatic impairment) or concomitant use with medicinal products known to induce QT prolongation and/or torsade de pointes (see section 4.5).</p><p dir="ltr">If patients with stable cardiac disease are treated, an ECG review should be considered before treatment is started.</p><p dir="ltr">If signs of cardiac arrhythmia occur during treatment with fluoxetine, the treatment should be withdrawn and an ECG should be performed.</p><p dir="ltr"><em>Serotonin syndrome or neuroleptic malignant syndrome-like events: </em>On rare occasions development of a serotonin syndrome or neuroleptic malignant syndrome-like events have been reported in association with treatment of fluoxetine, particularly when given in combination with other serotonergic (among others L-tryptophan) and/or neuroleptic drugs. As these syndromes may result in potentially life-threatening conditions, treatment with fluoxetine should be discontinued if such events (characterised by clusters of symptoms such as hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, mental status changes including confusion, irritability, extreme agitation progressing to delirium and coma) occur and supportive symptomatic treatment should be initiated.</p><p dir="ltr"><em>&nbsp;Mania: </em>Antidepressants should be used with caution in patients with a history of mania/hypomania. As with all antidepressants, fluoxetine should be discontinued in any patient entering a manic phase.</p><p dir="ltr"><em>&nbsp;Haemorrhage: </em>There have been reports of cutaneous bleeding abnormalities such as ecchymosis and purpura with SSRI&rsquo;s. Ecchymosis has been reported as an infrequent event during treatment with fluoxetine. Other haemorrhagic manifestations (e.g., gynaecological haemorrhages, gastrointestinal bleedings and other cutaneous or mucous bleedings) have been reported rarely. Caution is advised in patients taking SSRI&rsquo;s, particularly in concomitant use with oral anticoagulants, drugs known to affect platelet function (e.g. atypical antipsychotics such as clozapine, phenothiazines, most TCA&rsquo;s, aspirin, NSAID&rsquo;s) or other drugs that may increase risk of bleeding as well as in patients with a history of bleeding disorders.</p><p dir="ltr"><em>&nbsp;Seizures:</em><em> </em>Seizures are a potential risk with antidepressant drugs. Therefore, as with other antidepressants, fluoxetine should be introduced cautiously in patients who have a history of seizures. Treatment should be discontinued in any patient who develops seizures or where there is an increase in seizure frequency. Fluoxetine should be avoided in patients with unstable seizure disorders/epilepsy and patients with controlled epilepsy should be carefully monitored.</p><p dir="ltr"><em>&nbsp;Electroconvulsive Therapy (ECT): </em>There have been rare reports of prolonged seizures in patients on fluoxetine receiving ECT treatment, therefore caution is advisable.</p><p dir="ltr"><em>&nbsp;</em><em>Tamoxifen: </em>Fluoxetine, a potent inhibitor of CYP2D6, may lead to reduced concentrations of endoxifen, one of the most important active metabolites of tamoxifen. Therefore, fluoxetine should whenever possible be avoided during tamoxifen treatment (see section 4.5).</p><p dir="ltr">&nbsp;<em>Akathisia/psychomotor restlessness: </em>The use of fluoxetine has been associated with the development of akathisia, characterised by a subjectively unpleasant or distressing restlessness and need to move often accompanied by an inability to sit or stand still. This is most likely to occur within the first few weeks of treatment. In patients who develop these symptoms, increasing the dose may be detrimental.</p><p dir="ltr"><em>&nbsp;Diabetes: </em>In patients with diabetes, treatment with an SSRI may alter glycaemic control. Hypoglycaemia has occurred during therapy with fluoxetine and hyperglycaemia has developed following discontinuation. Insulin and/or oral hypoglycaemic dosage may need to be adjusted.</p><p dir="ltr"><em>&nbsp;Hepatic/Renal Function: </em>Fluoxetine is extensively metabolised by the liver and excreted by the kidneys. A lower dose, e.g., alternate day dosing, is recommended in patients with significant hepatic dysfunction. When given fluoxetine 20 mg/day for 2 months, patients with severe renal failure (GFR &lt;10 ml/min) requiring dialysis showed no difference in plasma levels of fluoxetine or norfluoxetine compared to controls with normal renal function.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Rash and allergic reactions</u></p><p dir="ltr">Rash, anaphylactoid events and progressive systemic events, sometimes serious (involving skin, kidney, liver or lung), have been reported. Upon the appearance of rash or of other allergic phenomena for which an alternative aetiology cannot be identified, fluoxetine should be discontinued.</p><p dir="ltr"><em>Weight loss: </em></p><p dir="ltr">Weight loss may occur in patients taking fluoxetine, but it is usually proportional to baseline body weight.</p><p dir="ltr"><em>Withdrawal symptoms seen on discontinuation of SSRI treatment:</em> Withdrawal symptoms when treatment is discontinued are common, particularly if discontinuation is abrupt (see section 4.8). In clinical trials, adverse events seen on treatment discontinuation occurred in approximately 60% of patients in both the fluoxetine and placebo groups. Of these adverse events, 17% in the fluoxetine group and 12% in the placebo group were severe in nature.</p><p dir="ltr">The risk of withdrawal symptoms may be dependent on several factors, including the duration and dose of therapy and the rate of dose reduction. Dizziness, sensory disturbances (including paraesthesia), sleep disturbances (including insomnia and intense dreams), asthenia, agitation or anxiety, nausea and/or vomiting, tremor, and headache are the most commonly reported reactions. Generally, these symptoms are mild to moderate; however, in some patients they may be severe in intensity. They usually occur within the first few days of discontinuing treatment. Generally, these symptoms are self-limiting and usually resolve within 2 weeks, though in some individuals they may be prolonged (2-3 months or more). It is therefore advised that Anxetin<sup>&reg;</sup> should be gradually tapered when discontinuing treatment over a period of at least one to two weeks, according to the patient&#39;s needs (see &#39;<em>Withdrawal symptoms seen on discontinuation of Anxetin</em><sup>&reg;</sup> &#39;, section 4.2).</p><p dir="ltr"><em>Mydriasis</em>: Mydriasis has been reported in association with fluoxetine; therefore, caution should be used when prescribing fluoxetine in patients with raised intraocular pressure or those at risk of acute narrow-angle glaucoma.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Half-life:</em> The long elimination half-lives of both fluoxetine and norfluoxetine should be borne in mind (see section 5.2) when considering pharmacodynamic or pharmacokinetic drug interactions (e.g., when switching from fluoxetine to other antidepressants).</p><p dir="ltr"><em><u>Contra-indicated combinations</u></em></p><p dir="ltr"><em>Irreversible, non-selective monoamine oxidase inhibitors (e.g. iproniazid)</em>: Some cases of serious and sometimes fatal reactions have been reported in patients receiving an SSRI in combination with an irreversible, non-selective monoamine oxidase inhibitor (MAOI).</p><p dir="ltr">These cases presented with features resembling serotonin syndrome (which may be confounded with [or diagnosed as] neuroleptic malignant syndrome). Cyproheptadine or dantrolene may benefit patients experiencing such reactions. Symptoms of a drug interaction with a MAOI include: hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, mental status changes that include confusion, irritability and extreme agitation progressing to delirium and coma.</p><p dir="ltr">Therefore, fluoxetine is contra-indicated in combination with an irreversible, non-selective MAOI (see section 4.3). Because of the two weeks-lasting effect of the latter, treatment of fluoxetine should only be started 2 weeks after discontinuation of an irreversible, non-selective MAOI. Similarly, at least 5 weeks should elapse after discontinuing fluoxetine treatment before starting an irreversible, non-selective MAOI.</p><p dir="ltr">&nbsp;<em>Metoprolol used in cardiac failure</em>: risk of metoprolol adverse events, including excessive bradycardia, may be increased because of an inhibition of its metabolism by fluoxetine (see section 4.3).</p><p dir="ltr"><em><u>Not recommended combinations</u></em></p><p dir="ltr"><em>&nbsp;</em><em>Tamoxifen</em>: Pharmacokinetic interaction between CYP2D6 inhibitors and tamoxifen, showing a 65-75&nbsp;% reduction in plasma levels of one of the more active forms of the tamoxifen, i.e. endoxifen, has been reported in the literature. Reduced efficacy of tamoxifen has been reported with concomitant usage of some SSRI antidepressants in some studies. As a reduced effect of tamoxifen cannot be excluded, co-administration with potent CYP2D6 inhibitors (including fluoxetine) should whenever possible be avoided (see section 4.4).</p><p dir="ltr">&nbsp;<em>Alcohol</em>: In formal testing, fluoxetine did not raise blood alcohol levels or enhance the effects of alcohol. However, the combination of SSRI treatment and alcohol is not advisable.</p><p dir="ltr">&nbsp;<em>MAOI-A including linezolid and methylthioninium chloride (methylene blue)</em>: Risk of serotonin syndrome including diarrhoea, tachycardia, sweating, tremor, confusion or coma. If concomitant use of these active substances with fluoxetine cannot be avoided, close clinical monitoring should be undertaken and the concomitant agents should be initiated at the lower recommended doses (see section 4.4).</p><p dir="ltr">&nbsp;<em>Mequitazine</em>: risk of mequitazine adverse events (such as QT prolongation) may be increased because of an inhibition of its metabolism by fluoxetine.</p><p dir="ltr"><em>&nbsp;<u>Combinations requiring caution</u></em></p><p dir="ltr"><em>Phenytoin:</em> Changes in blood levels have been observed when combined with &nbsp;&nbsp;fluoxetine. In some cases manifestations of toxicity have occurred. Consideration should be given to using conservative titration schedules of the concomitant drug and to monitoring clinical status.</p><p dir="ltr"><em>Serotoninergic drugs (lithium, tramadol, triptans, tryptophan, selegiline (MAOI-B), St. John&rsquo;s Wort (Hypericum perforatum))</em>: There have been reports of mild serotonin syndrome when SSRIs were given with drugs also having a serotoninergic effect. Therefore, the concomitant use of fluoxetine with these drugs should be undertaken with caution, with closer and more frequent clinical monitoring (see section 4.4).</p><p dir="ltr"><em>QT interval prolongation</em>: Pharmacokinetic and pharmacodynamic studies between fluoxetine and other medicinal products that prolong the QT interval have not been performed. An additive effect of fluoxetine and these medicinal products cannot be excluded. Therefore, co-administration of fluoxetine with medicinal products that prolong the QT interval, such as Class IA and III antiarrhythmics, antipsychotics (e.g. phenothiazine derivatives, pimozide, haloperidol), tricyclic antidepressants, certain antimicrobial agents (e.g. sparfloxacin, moxifloxacin, erythromycin IV, pentamidine), anti-malaria treatment particularly halofantrine, certain antihistamines (astemizole, mizolastine), should be used with caution (see sections 4.4, 4.8 and 4.9).</p><p dir="ltr"><em>Drugs affecting haemostasis (oral anticoagulants, whatever their mechanism, platelets antiaggregants including aspirin and NSAIDs)</em>: risk of increased bleeding. Clinical monitoring, and more frequent monitoring of INR with oral anticoagulants, should be made. A dose adjustment during the fluoxetine treatment and after its discontinuation may be suitable (see sections 4.4 and 4.8).</p><p dir="ltr">&nbsp;<em>Cyproheptadine</em>: There are individual case reports of reduced antidepressant activity of fluoxetine when used in combination with cyproheptadine.</p><p dir="ltr">&nbsp;<em>Drugs inducing hyponatremia</em>: Hyponatremia is an undesirable effect of fluoxetine. Use in combination with other agents associated with hyponatremia (e.g. diuretics, desmopressin, carbamazepine and oxcarbazepine) may lead to an increased risk (see section 4.8).</p><p dir="ltr">&nbsp;<em>Drugs lowering the epileptogenic threshold</em>: Seizures are an undesirable effect of fluoxetine. Use in combination with other agents which may lower the seizure threshold (for example, TCAs, other SSRIs, phenothiazines, butyrophenones, mefloquine, chloroquine, bupropion, tramadol) may lead to an increased risk.</p><p dir="ltr">&nbsp;<em>Other drugs metabolised by CYP2D6</em>: Fluoxetine is a strong inhibitor of CYP2D6 enzyme, therefore concomitant therapy with drugs also metabolised by this enzyme system may lead to drug interactions, notably those having a narrow therapeutic index (such as flecainide, propafenone and nebivolol) and those that are titrated, but also with atomoxetine, carbamazepine, tricyclic antidepressants and risperidone. They should be initiated at or adjusted to the low end of their dose range. This may also apply if fluoxetine has been taken in the previous 5 weeks.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Pregnancy</u></p><p dir="ltr">Some epidemiological studies suggest an increased risk of cardiovascular defects associated with the use of fluoxetine during the first trimester. The mechanism is unknown. Overall the data suggest that the risk of having an infant with a cardiovascular defect following maternal fluoxetine exposure is in the region of 2/100 compared with an expected rate for such defects of approximately 1/100 in the general population.</p><p dir="ltr">Epidemiological data have suggested that the use of SSRIs in pregnancy, particularly in late pregnancy, may increase the risk of persistent pulmonary hypertension in the newborn (PPHN). The observed risk was approximately 5 cases per 1000 pregnancies. In the general population 1 to 2 cases of PPHN per 1000 pregnancies occur.</p><p dir="ltr">Fluoxetine should not be used during pregnancy unless the clinical condition of the woman requires treatment with fluoxetine and justifies the potential risk to the foetus. Abrupt discontinuation of therapy should be avoided during pregnancy (see section 4.2 &ldquo;Posology and method of administration&rdquo;). If fluoxetine is used during pregnancy, caution should be exercised, especially during late pregnancy or just prior to the onset of labour since some other effects have been reported in neonates: irritability, tremor, hypotonia, persistent crying, difficulty in sucking or in sleeping. These symptoms may indicate either serotonergic effects or a withdrawal syndrome. The time to occur and the duration of these symptoms may be related to the long half-life of fluoxetine (4-6 days) and its active metabolite, norfluoxetine (4-16 days).</p><p dir="ltr"><u>Breastfeeding </u></p><p dir="ltr">Fluoxetine and its metabolite norfluoxetine, are known to be excreted in human breast milk. Adverse events have been reported in breastfeeding infants. If treatment with fluoxetine is considered necessary, discontinuation of breastfeeding should be considered; however, if breastfeeding is continued, the lowest effective dose of fluoxetine should be prescribed.</p><p dir="ltr"><u>Fertility</u></p><p dir="ltr">Animal data have shown that fluoxetine may affect sperm quality (see section 5.3).</p><p dir="ltr">Human case reports with some SSRI&#39;s have shown that an effect on sperm quality is reversible.</p><p dir="ltr">Impact on human fertility has not been observed so far.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Although fluoxetine has been shown not to affect psychomotor performance in healthy volunteers, any psychoactive drug may impair judgement or skills. Patients should be advised to avoid driving a car or operating hazardous machinery until they are reasonably certain that their performance is not affected.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">a. <u>Summary of the safety profile</u></p><p dir="ltr">The most commonly reported adverse reactions in patients treated with fluoxetine were headache, nausea, insomnia, fatigue and diarrhoea. Undesirable effects may decrease in intensity and frequency with continued treatment and do not generally lead to cessation of therapy.</p><p dir="ltr">b. <u>Tabulated list of adverse reactions</u></p><p dir="ltr">The table below gives the adverse reactions observed with fluoxetine treatment in adult and paediatric populationsin. Some of these adverse reactions are in common with other SSRIs.</p><p dir="ltr">The following Frequencies have been calculated from clinical trials in adults (n= 9297) and from spontaneous reporting frequency estimate: Very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000).</p><table border="1" cellspacing="0" cellpadding="0" dir="ltr" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Very Common</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Blood and lymphatic system disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td colspan="3" style="vertical-align:top"><p>Thrombocytopenia</p><p>Neutropenia</p><p>Leucopenia</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Immune system disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td colspan="3" style="vertical-align:top"><p>Anaphylactic reaction</p><p>Serum sickness</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Endocrine disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td colspan="3" style="vertical-align:top"><p>Inappropriate antidiuretic hormone secretion</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Metabolism and nutrition disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Decreased appetite<sup>1</sup></p></td><td style="vertical-align:top">&nbsp;</td><td colspan="3" style="vertical-align:top"><p>Hyponatraemia</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Psychiatric disorders</em></p></td></tr><tr><td style="vertical-align:top"><p>Insomnia<sup>2</sup></p></td><td style="vertical-align:top"><p>Anxiety</p><p>Nervousness</p><p>Restlessness</p><p>Tension</p><p>Libido decreased<sup>3</sup></p><p>Sleep disorder</p><p>Abnormal dreams<sup>4</sup></p></td><td style="vertical-align:top"><p>Depersonalisation</p><p>Elevated mood</p><p>Euphoric mood</p><p>Thinking abnormal</p><p>Orgasm abnormal<sup>5</sup></p><p>Bruxism Suicidal thoughts and behaviour <sup>6</sup></p></td><td colspan="3" style="vertical-align:top"><p>Hypomania</p><p>Mania</p><p>Hallucinations</p><p>Agitation</p><p>Panic attacks</p><p>Confusion</p><p>Dysphemia</p><p>Aggression</p><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Nervous system disorders</em></p></td></tr><tr><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Disturbance in attention</p><p>Dizziness</p><p>Dysgeusia</p><p>Lethargy</p><p>Somnolence<sup>7</sup></p><p>Tremor</p></td><td style="vertical-align:top"><p>Psychomotor</p><p>Dyskinesia</p><p>Ataxia</p><p>Balance disorder</p><p>Myoclonus Memory impairment</p></td><td colspan="3" style="vertical-align:top"><p>Convulsion</p><p>Akathisia</p><p>Buccoglossal syndrome Serotonin syndrome</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Eye disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Vision blurred</p></td><td style="vertical-align:top"><p>Mydriasis</p></td><td colspan="3" style="vertical-align:top">&nbsp;</td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Ear and labyrinth disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Tinnitus</p></td><td colspan="3" style="vertical-align:top">&nbsp;</td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Cardiac disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Palpitations</p><p>Electrocardio-gram QT prolonged</p></td><td style="vertical-align:top">&nbsp;</td><td colspan="3" style="vertical-align:top"><p>Ventricular arrhythmia including torsade de pointes</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Vascular disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Flushing<sup>8</sup></p></td><td style="vertical-align:top"><p>Hypotension</p></td><td colspan="3" style="vertical-align:top"><p>Vasculitis</p><p>Vasodilatation</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Respiratory, thoracic and mediastinal disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Yawning</p></td><td style="vertical-align:top"><p>Dyspnoea Epistaxis</p></td><td colspan="3" style="vertical-align:top"><p>Pharyngitis</p><p>Pulmonary events (inflammatory processes of varying histopathology and/or fibrosis)<sup>9</sup></p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Gastrointestinal disorders</em></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhoea</p><p>Nausea</p></td><td style="vertical-align:top"><p>Vomiting</p><p>Dyspepsia</p><p>Dry mouth</p></td><td colspan="2" style="vertical-align:top"><p>Dysphagia Gastrointestinal haemorrhage<sup>10</sup></p></td><td colspan="2" style="vertical-align:top"><p>Oesophageal pain</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Hepato-biliary disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td colspan="3" style="vertical-align:top"><p>idiosyncratic hepatitis</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Skin and subcutaneous tissue disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rash<sup>11</sup></p><p>Urticaria</p><p>Pruritus</p><p>Hyperhidrosis</p></td><td style="vertical-align:top"><p>Alopecia</p><p>Increased tendency to bruise</p><p>Cold sweat</p></td><td colspan="3" style="vertical-align:top"><p>Angioedema</p><p>Ecchymosis</p><p>Photosensitivity reaction</p><p>Purpura</p><p>Erythema multiforme</p><p>Stevens-Johnson syndrome</p><p>Toxic Epidermal Necrolysis (Lyell Syndrome)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Musculoskeletal and connective tissue disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Arthralgia</p></td><td style="vertical-align:top"><p>Muscle twitching</p></td><td colspan="3" style="vertical-align:top"><p>Myalgia</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Renal and urinary disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Frequent urination<sup>12</sup></p></td><td style="vertical-align:top"><p>Dysuria</p></td><td colspan="3" style="vertical-align:top"><p>Urinary retention Micturition disorder</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Reproductive system and breast disorders</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Gynaecological bleeding<sup>13</sup></p><p>Erectile dysfunction</p><p>Ejaculation disorder<sup>14</sup></p></td><td style="vertical-align:top"><p>Sexual dysfunction</p></td><td colspan="3" style="vertical-align:top"><p>Galactorrhoea, Hyperprolactinaemia</p><p>Priapism</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>General disorders and administration site conditions</em></p></td></tr><tr><td style="vertical-align:top"><p>Fatigue<sup>15</sup></p></td><td style="vertical-align:top"><p>Feeling jittery</p><p>Chills</p></td><td style="vertical-align:top"><p>Malaise</p><p>Feeling abnormal</p><p>Feeling cold</p><p>Feeling hot</p></td><td colspan="3" style="vertical-align:top"><p>Mucosal haemorrhage</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><em>Investigations</em></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Weight decrease</p></td><td style="vertical-align:top"><p>Abnormal liver function tests</p></td><td colspan="3" style="vertical-align:top">&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p dir="ltr"><sup>1</sup> Includes anorexia</p><p dir="ltr">2 Includes early morning awakening, initial insomnia, middle insomnia</p><p dir="ltr">3 Includes loss of libido</p><p dir="ltr">4 Includes nightmares</p><p dir="ltr">5 Includes anorgasmia</p><p dir="ltr">6 Includes completed suicide, depression suicidal, intentional self-injury, self-injurious ideation, suicidal behaviour, suicidal ideation, suicide attempt, morbid thoughts, self-injurious behaviour. These symptoms may be due to underlying disease</p><p dir="ltr">7 Includes hypersomnia, sedation</p><p dir="ltr">8 &nbsp;Includes hot flush</p><p dir="ltr">9 &nbsp;Includes atelectasis, interstitial lung disease, pneumonitis</p><p dir="ltr">10 &nbsp;Includes most frequently gingival bleeding, haematemesis, haematochezia, rectal haemorrhage, diarrhoea haemorrhagic, melaena, and gastric ulcerhaemorrhage</p><p dir="ltr">11 &nbsp;Includes erythema, exfoliative rash, heat rash, rash, rash erythematous, rash follicular, rash generalized, rash macular, rash macular-papular, rash morbilliform, rash papular, rash pruritic, rash vesicular, umbilical erythema rash</p><p dir="ltr">12 &nbsp;Includes pollakiuria</p><p dir="ltr">13Includes cervix haemorrhage, uterine dysfunction, uterine bleeding, genital haemorrhage, menometrorhagia, menorrhagia, metrorrhagia, polymenorrhea, postmenopausal haemorrhage, uterine haemorrhage, vaginal haemorrhage</p><p dir="ltr">14Includes ejaculation failure, ejaculation dysfunction, premature ejaculation, ejaculation delayed, retrograde ejaculation</p><p dir="ltr">&nbsp;</p><p dir="ltr">15 Includes asthenia</p><p dir="ltr">c. Description of selected adverse reactions</p><p dir="ltr">Suicide/suicidal thoughts or clinical worsening: Cases of suicidal ideation and suicidal behaviour have been reported during fluoxetine therapy or early after treatment discontinuation (see section 4.4).</p><p dir="ltr">Bone fractures: Epidemiological studies, mainly conducted in patients 50 years of age and older, show an increased risk of bone fractures in patients receiving SSRIs and TCAs. The mechanism leading to the risk is unknown.</p><p dir="ltr">Withdrawal symptoms seen on discontinuation of fluoxetine treatments: Discontinuation of fluoxetine commonly leads to withdrawal symptoms. Dizziness, sensory disturbances (including paraesthesia), sleep disturbances (including insomnia and intense dreams), asthenia, agitation or anxiety, nausea and/or vomiting, tremor and headache are the most commonly reported reactions. Generally these events are mild to moderate and are self-limiting, however, in some patients they may be severe and/or prolonged (see section 4.4). It is therefore advised that when fluoxetine treatment is no longer required, gradual discontinuation by dose tapering should be carried out (see sections 4.2 and 4.4).</p><p dir="ltr">d. Paediatric population (see sections 4.4 and 5.1)</p><p dir="ltr">Adverse reactions that have been observed specifically or with a different frequency in this population are described below. Frequencies for these events are based on paediatric clinical trial exposures (n = 610).</p><p dir="ltr">In paediatric clinical trials, suicide-related behaviours (suicide attempt and suicidal thoughts), hostility (the events reported were: anger, irritability, aggression, agitation, activation syndrome), manic reactions, including mania and hypomania (no prior episodes reported in these patients) and epistaxis, were commonly reported and were more frequently observed among children and adolescents treated with antidepressants compared to those treated with placebo.</p><p dir="ltr">Isolated cases of growth retardation have been reported from clinical use (See also section 5.1).</p><p dir="ltr">In paediatric clinical trials, fluoxetine treatment was also associated with a decrease in alkaline phosphatase levels.</p><p dir="ltr">Isolated cases of adverse events potentially indicating delayed sexual maturation or sexual dysfunction have been reported from paediatric clinical use (See also section 5.3).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>To report any side effects:</strong></p><p dir="ltr">The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p dir="ltr">&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p dir="ltr">&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966- 11-2038222, Ext 2317, 2356, 2340</p><p dir="ltr">&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p dir="ltr">&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: <u>npc.drug@sfda.gov.sa</u></p><p dir="ltr">&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: <u>www.sfda.gov.sa/npc</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Symptoms</u></p><p dir="ltr">Cases of overdose of fluoxetine alone usually have a mild course. Symptoms of overdose have included nausea, vomiting, seizures, cardiovascular dysfunction ranging from asymptomatic arrhythmias (including nodal rhythm and ventricular arrhythmias) or ECG changes indicative of QTc prolongation to cardiac arrest (including very rare cases of Torsade de Pointes), pulmonary dysfunction, and signs of altered CNS status ranging from excitation to coma. Fatality attributed to overdose of fluoxetine alone has been extremely rare.</p><p dir="ltr"><u>Management</u></p><p dir="ltr">Cardiac and vital signs monitoring are recommended, along with general symptomatic and supportive measures. No specific antidote is known.</p><p dir="ltr">Forced diuresis, dialysis, haemoperfusion, and exchange transfusion are unlikely to be of benefit. Activated charcoal, which may be used with sorbitol, may be as or more effective than emesis or lavage. In managing overdosage, consider the possibility of multiple drug involvement. An extended time for close medical observation may be needed in patients who have taken excessive quantities of a tricyclic antidepressant if they are also taking, or have recently taken, fluoxetine.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Pharmacotherapeutic group:</em> Selective serotonin reuptake inhibitors. <em>ATC code:</em> N06A B03.</p><p dir="ltr"><u>Mechanism of action</u></p><p dir="ltr">Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as &alpha;<sub>1</sub>-, &alpha;<sub>2</sub>-, and &beta;-adrenergic; serotonergic; dopaminergic; histaminergic<sub>1</sub>; muscarinic; and GABA receptors.</p><p dir="ltr"><u>Clinical efficacy and safety</u></p><p dir="ltr"><em>Major depressive episodes:</em> Clinical trials in patients with major depressive episodes have been conducted versus placebo and active controls. Fluoxetine has been shown to be significantly more effective than placebo, as measured by the Hamilton Depression Rating Scale (HAM-D). In these studies, fluoxetine produced a significantly higher rate of response (defined by a 50% decrease in the HAM-D score) and remission compared to placebo.</p><p dir="ltr"><em>Dose response:</em> In the fixed dose studies of patients with major depression there is a flat dose response curve, providing no suggestion of advantage in terms of efficacy for using higher than the recommended doses. However, it is clinical experience that uptitrating might be beneficial for some patients.</p><p dir="ltr"><em>Obsessive-compulsive disorder:</em> In short-term trials (under 24 weeks), fluoxetine was shown to be significantly more effective than placebo. There was a therapeutic effect at 20mg/day, but higher doses (40 or 60mg/day) showed a higher response rate. In long-term studies (three short-term studies extension phase and a relapse prevention study), efficacy has not been shown.</p><p dir="ltr"><em>Bulimia nervosa:</em> In short-term trials (under 16 weeks), in out-patients fulfilling DSM-III-R-criteria for bulimia nervosa, fluoxetine 60mg/day was shown to be significantly more effective than placebo for the reduction of bingeing and purging activities. However, for long-term efficacy no conclusion can be drawn.</p><p dir="ltr"><em>Pre-Menstrual Dysphoric Disorder</em>: Two placebo-controlled studies were conducted in patients meeting pre-menstrual dysphoric disorder (PMDD) diagnostic criteria according to DSM-IV. Patients were included if they had symptoms of sufficient severity to impair social and occupational function and relationships with others. Patients using oral contraceptives were excluded. In the first study of continuous 20mg daily dosing for 6 cycles, improvement was observed in the primary efficacy parameter (irritability, anxiety and dysphoria). In the second study, with intermittent luteal phase dosing (20mg daily for 14 days) for 3 cycles, improvement was observed in the primary efficacy parameter (Daily Record of Severity of Problems score). However, definitive conclusions on efficacy and duration of treatment cannot be drawn from these studies.</p><p dir="ltr"><u>Paediatric population</u></p><p dir="ltr"><em>Major depressive episodes:</em> Clinical trials in children and adolescents aged 8 years and above have been conducted versus placebo. Fluoxetine, at a dose of 20mg, has been shown to be significantly more effective than placebo in two short-term pivotal studies, as measured by the reduction of Childhood Depression Rating Scale-Revised (CDRS-R) total scores and Clinical Global Impression of Improvement (CGI-I) scores. In both studies, patients met criteria for moderate to severe MDD (DSM-III or DSM-IV) at three different evaluations by practising child psychiatrists. Efficacy in the fluoxetine trials may depend on the inclusion of a selective patient population (one that has not spontaneously recovered within a period of 3-5 weeks and whose depression persisted in the face of considerable attention). There is only limited data on safety and efficacy beyond 9 weeks. In general, efficacy of fluoxetine was modest. Response rates (the primary endpoint, defined as a 30% decrease in the CDRS-R score) demonstrated a statistically significant difference in one of the two pivotal studies (58% for fluoxetine versus 32% for placebo, <em>P</em> = 0.013; and 65% for fluoxetine versus 54% for placebo, <em>P</em> = 0.093). In these two studies, the mean absolute changes in CDRS-R from baseline to endpoint were 20 for fluoxetine versus 11 for placebo, <em>P</em> = 0.002; and 22 for fluoxetine versus 15 for placebo, <em>P</em> &lt;0.001.</p><p dir="ltr"><em>Effects on growth, see sections 4.4 and 4.8: </em>After 19 weeks of treatment, paediatric subjects treated with fluoxetine in a clinical trial gained an average of 1.1 cm less in height (p=0.004) and 1.1 kg less in weight (p=0.008) than subjects treated with placebo.</p><p dir="ltr">In a retrospective matched control observational study with a mean of 1.8 years of exposure to fluoxetine, paediatric subjects treated with fluoxetine had no difference in growth adjusted for expected growth in height from their matched, untreated controls (0.0 cm, p=0.9673).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Absorption:</em> Fluoxetine is well absorbed from the gastro-intestinal tract after oral administration. The bioavailability is not affected by food intake.</p><p dir="ltr"><em>Distribution:</em> Fluoxetine is extensively bound to plasma proteins (about 95%) and it is widely distributed (volume of distribution: 20-40 l/kg). Steady-state plasma concentrations are achieved after dosing for several weeks. Steady-state concentrations after prolonged dosing are similar to concentrations seen at 4 to 5 weeks.</p><p dir="ltr"><em>biotransformation:</em> Fluoxetine has a non-linear pharmacokinetic profile with first pass liver effect. Maximum plasma concentration is generally achieved 6 to 8 hours after administration. Fluoxetine is extensively metabolised by the polymorphic enzyme CYP2D6. Fluoxetine is primarily metabolised by the liver to the active metabolite norfluoxetine (desmethylfluoxetine), by desmethylation.</p><p dir="ltr"><em>Elimination:</em> The elimination half-life of fluoxetine is 4 to 6 days and for norfluoxetine 4 to 16 days. These long half-lives are responsible for persistence of the drug for 5-6 weeks after discontinuation. Excretion is mainly (about 60%) via the kidney. Fluoxetine is secreted into breast milk.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><em><u>Special populations</u></em></p><p dir="ltr"><em>Elderly:</em> Kinetic parameters are not altered in healthy elderly when compared to younger subjects.</p><p dir="ltr"><em>Paediatric population:</em> The mean fluoxetine concentration in children is approximately 2-fold higher than that observed in adolescents and the mean norfluoxetine concentration 1.5-fold higher. Steady-state plasma concentrations are dependent on body weight and are higher in lower weight children (see section 4.2). As in adults, fluoxetine and norfluoxetine accumulated extensively following multiple oral dosing; steady-state concentrations were achieved within 3 to 4 weeks of daily dosing.</p><p dir="ltr"><em>Hepatic insufficiency:</em> In case of hepatic insufficiency (alcoholic cirrhosis), fluoxetine and norfluoxetine half-lives are increased to 7 and 12 days, respectively. A lower or less frequent dose should be considered.</p><p dir="ltr"><em>Renal insufficiency:</em> After single-dose administration of fluoxetine in patients with mild, moderate, or complete (anuria) renal insufficiency, kinetic parameters have not been altered when compared to healthy volunteers. However, after repeated administration, an increase in steady-state plateau of plasma concentrations may be observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">There is no evidence of carcinogenicity or mutagenicity from in vitro or animal studies.</p><p dir="ltr"><em>Adult animal studies</em></p><p dir="ltr">In a 2-generation rat reproduction study, fluoxetine did not produce adverse effects on the mating or fertility of rats, was not teratogenic, and did not affect growth, development, or reproductive parameters of the offspring.</p><p dir="ltr">The concentrations in the diet provided doses approximately equivalent to 1.5, 3.9, and 9.7 mg fluoxetine/kg body weight.</p><p dir="ltr">Male mice treated daily for 3 months with fluoxetine in the diet at a dose approximately equivalent to 31 mg/kg showed a decrease in testis weight and hypospermatogenesis. However, this dose level exceeded the maximum-tolerated dose (MTD) as significant signs of toxicity were seen.</p><p dir="ltr"><em>Juvenile animal studies</em></p><p dir="ltr">In a juvenile toxicology study in CD rats, administration of 30 mg/kg/day of fluoxetine hydrochloride on postnatal days 21 to 90 resulted in irreversible testicular degeneration and necrosis, epididymal epithelial vacuolation, immaturity and inactivity of the female reproductive tract and decreased fertility. Delays in sexual maturation occurred in males (10 and 30 mg/kg/day) and females (30 mg/kg/day). The significance of these findings in humans is unknown. Rats administered 30 mg/kg also had decreased femur lengths compared with controls and skeletal muscle degeneration, necrosis and regeneration. At 10 mg/kg/day, plasma levels achieved in animals were approximately 0.8 to 8.8 fold (fluoxetine) and 3.6 to 23.2 fold (norfluoxetine) those usually observed in paediatric patients. At 3 mg/kg/day, plasma levels achieved in animals were approximately 0.04 to 0.5 fold (fluoxetine) and 0.3 to 2.1 fold (norfluoxetine) those usually achieved in paediatric patients.</p><p dir="ltr">A study in juvenile mice has indicated that inhibition of the serotonin transporter prevents the accrual of bone formation. This finding would appear to be supported by clinical findings. The reversibility of this effect has not been established.</p><p dir="ltr">Another study in juvenile mice (treated on postnatal days 4 to 21) has demonstrated that inhibition of the serotonin transporter had long lasting effects on the behaviour of the mice. There is no information on whether the effect was reversible. The clinical relevance of this finding has not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Magnesium stearate, microcrystalline cellulose, sodium starch glycolate, mannitol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 Months 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Protect from light. Store in a dry place. Do not store above 30<sup>&deg;</sup>C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Primary package: PVC film and aluminum foil.</p><p dir="ltr">Secondary package: Carton and leaflet.</p><p dir="ltr">Anxetin<sup>&reg;</sup> capsules are available in pack of 10 (1 strip contains 10 capsules), 20 (2 strips, each strip contains 10 capsules), 30 (3 strips, each strip contains 10 capsules), 500 (50 strips, each strip contains 10 capsules).</p><p dir="ltr">Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Medicines should not be disposed of via wastewater or household waste.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development & Investment Co. Ltd.
P.O. Box 9364 
Na’ur - Jordan

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                08/04/2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>